nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—Anorectal discomfort—Etoposide—sarcoma	0.048	0.048	CcSEcCtD
Bisacodyl—Abdominal cramps—Vincristine—sarcoma	0.048	0.048	CcSEcCtD
Bisacodyl—Haematochezia—Epirubicin—sarcoma	0.0366	0.0366	CcSEcCtD
Bisacodyl—Colitis—Thiotepa—sarcoma	0.0351	0.0351	CcSEcCtD
Bisacodyl—Haematochezia—Doxorubicin—sarcoma	0.0338	0.0338	CcSEcCtD
Bisacodyl—Anorectal discomfort—Epirubicin—sarcoma	0.0269	0.0269	CcSEcCtD
Bisacodyl—Anorectal discomfort—Doxorubicin—sarcoma	0.0249	0.0249	CcSEcCtD
Bisacodyl—Dehydration—Thiotepa—sarcoma	0.0247	0.0247	CcSEcCtD
Bisacodyl—Dehydration—Vincristine—sarcoma	0.0219	0.0219	CcSEcCtD
Bisacodyl—Dehydration—Mitoxantrone—sarcoma	0.0213	0.0213	CcSEcCtD
Bisacodyl—Cramp muscle—Etoposide—sarcoma	0.0172	0.0172	CcSEcCtD
Bisacodyl—Immune system disorder—Thiotepa—sarcoma	0.0166	0.0166	CcSEcCtD
Bisacodyl—Malnutrition—Thiotepa—sarcoma	0.016	0.016	CcSEcCtD
Bisacodyl—Colitis—Epirubicin—sarcoma	0.0141	0.0141	CcSEcCtD
Bisacodyl—Colitis—Doxorubicin—sarcoma	0.0131	0.0131	CcSEcCtD
Bisacodyl—Nervous system disorder—Thiotepa—sarcoma	0.0128	0.0128	CcSEcCtD
Bisacodyl—Immune system disorder—Etoposide—sarcoma	0.0119	0.0119	CcSEcCtD
Bisacodyl—Anaphylactic shock—Vincristine—sarcoma	0.0116	0.0116	CcSEcCtD
Bisacodyl—Nervous system disorder—Vincristine—sarcoma	0.0113	0.0113	CcSEcCtD
Bisacodyl—Anaphylactic shock—Mitoxantrone—sarcoma	0.0113	0.0113	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Thiotepa—sarcoma	0.0113	0.0113	CcSEcCtD
Bisacodyl—Shock—Mitoxantrone—sarcoma	0.0111	0.0111	CcSEcCtD
Bisacodyl—Muscle spasms—Etoposide—sarcoma	0.011	0.011	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Thiotepa—sarcoma	0.0107	0.0107	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Dactinomycin—sarcoma	0.0106	0.0106	CcSEcCtD
Bisacodyl—Abdominal pain—Thiotepa—sarcoma	0.0103	0.0103	CcSEcCtD
Bisacodyl—Abdominal pain—Dactinomycin—sarcoma	0.0102	0.0102	CcSEcCtD
Bisacodyl—Loss of consciousness—Etoposide—sarcoma	0.0101	0.0101	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Vincristine—sarcoma	0.00999	0.00999	CcSEcCtD
Bisacodyl—Dehydration—Epirubicin—sarcoma	0.00994	0.00994	CcSEcCtD
Bisacodyl—Hypersensitivity—Thiotepa—sarcoma	0.00961	0.00961	CcSEcCtD
Bisacodyl—Hypersensitivity—Dactinomycin—sarcoma	0.00954	0.00954	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Vincristine—sarcoma	0.00946	0.00946	CcSEcCtD
Bisacodyl—Anaphylactic shock—Etoposide—sarcoma	0.00937	0.00937	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00921	0.00921	CcSEcCtD
Bisacodyl—Dehydration—Doxorubicin—sarcoma	0.0092	0.0092	CcSEcCtD
Bisacodyl—Abdominal pain—Vincristine—sarcoma	0.00915	0.00915	CcSEcCtD
Bisacodyl—Diarrhoea—Thiotepa—sarcoma	0.00893	0.00893	CcSEcCtD
Bisacodyl—Abdominal pain—Mitoxantrone—sarcoma	0.00891	0.00891	CcSEcCtD
Bisacodyl—Diarrhoea—Dactinomycin—sarcoma	0.00886	0.00886	CcSEcCtD
Bisacodyl—Dizziness—Thiotepa—sarcoma	0.00863	0.00863	CcSEcCtD
Bisacodyl—Hypersensitivity—Vincristine—sarcoma	0.00852	0.00852	CcSEcCtD
Bisacodyl—Hypersensitivity—Mitoxantrone—sarcoma	0.0083	0.0083	CcSEcCtD
Bisacodyl—Vomiting—Thiotepa—sarcoma	0.00829	0.00829	CcSEcCtD
Bisacodyl—Vomiting—Dactinomycin—sarcoma	0.00823	0.00823	CcSEcCtD
Bisacodyl—Headache—Thiotepa—sarcoma	0.00817	0.00817	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Etoposide—sarcoma	0.00809	0.00809	CcSEcCtD
Bisacodyl—Diarrhoea—Vincristine—sarcoma	0.00792	0.00792	CcSEcCtD
Bisacodyl—Nausea—Thiotepa—sarcoma	0.00775	0.00775	CcSEcCtD
Bisacodyl—Diarrhoea—Mitoxantrone—sarcoma	0.00771	0.00771	CcSEcCtD
Bisacodyl—Nausea—Dactinomycin—sarcoma	0.00769	0.00769	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Etoposide—sarcoma	0.00766	0.00766	CcSEcCtD
Bisacodyl—Dizziness—Vincristine—sarcoma	0.00765	0.00765	CcSEcCtD
Bisacodyl—Abdominal pain—Etoposide—sarcoma	0.00741	0.00741	CcSEcCtD
Bisacodyl—Vomiting—Vincristine—sarcoma	0.00736	0.00736	CcSEcCtD
Bisacodyl—Headache—Vincristine—sarcoma	0.00725	0.00725	CcSEcCtD
Bisacodyl—Vomiting—Mitoxantrone—sarcoma	0.00716	0.00716	CcSEcCtD
Bisacodyl—Headache—Mitoxantrone—sarcoma	0.00706	0.00706	CcSEcCtD
Bisacodyl—Hypersensitivity—Etoposide—sarcoma	0.0069	0.0069	CcSEcCtD
Bisacodyl—Nausea—Vincristine—sarcoma	0.00687	0.00687	CcSEcCtD
Bisacodyl—Nausea—Mitoxantrone—sarcoma	0.00669	0.00669	CcSEcCtD
Bisacodyl—Immune system disorder—Epirubicin—sarcoma	0.00668	0.00668	CcSEcCtD
Bisacodyl—Malnutrition—Epirubicin—sarcoma	0.00644	0.00644	CcSEcCtD
Bisacodyl—Diarrhoea—Etoposide—sarcoma	0.00641	0.00641	CcSEcCtD
Bisacodyl—Dizziness—Etoposide—sarcoma	0.0062	0.0062	CcSEcCtD
Bisacodyl—Muscle spasms—Epirubicin—sarcoma	0.00619	0.00619	CcSEcCtD
Bisacodyl—Immune system disorder—Doxorubicin—sarcoma	0.00618	0.00618	CcSEcCtD
Bisacodyl—Vomiting—Etoposide—sarcoma	0.00596	0.00596	CcSEcCtD
Bisacodyl—Malnutrition—Doxorubicin—sarcoma	0.00596	0.00596	CcSEcCtD
Bisacodyl—Headache—Etoposide—sarcoma	0.00587	0.00587	CcSEcCtD
Bisacodyl—Syncope—Epirubicin—sarcoma	0.00577	0.00577	CcSEcCtD
Bisacodyl—Muscle spasms—Doxorubicin—sarcoma	0.00573	0.00573	CcSEcCtD
Bisacodyl—Loss of consciousness—Epirubicin—sarcoma	0.00566	0.00566	CcSEcCtD
Bisacodyl—Nausea—Etoposide—sarcoma	0.00557	0.00557	CcSEcCtD
Bisacodyl—Syncope—Doxorubicin—sarcoma	0.00534	0.00534	CcSEcCtD
Bisacodyl—Anaphylactic shock—Epirubicin—sarcoma	0.00525	0.00525	CcSEcCtD
Bisacodyl—Loss of consciousness—Doxorubicin—sarcoma	0.00523	0.00523	CcSEcCtD
Bisacodyl—Shock—Epirubicin—sarcoma	0.00517	0.00517	CcSEcCtD
Bisacodyl—Nervous system disorder—Epirubicin—sarcoma	0.00515	0.00515	CcSEcCtD
Bisacodyl—Anaphylactic shock—Doxorubicin—sarcoma	0.00486	0.00486	CcSEcCtD
Bisacodyl—Shock—Doxorubicin—sarcoma	0.00478	0.00478	CcSEcCtD
Bisacodyl—Nervous system disorder—Doxorubicin—sarcoma	0.00477	0.00477	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Epirubicin—sarcoma	0.00454	0.00454	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Epirubicin—sarcoma	0.0043	0.0043	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Doxorubicin—sarcoma	0.0042	0.0042	CcSEcCtD
Bisacodyl—Abdominal pain—Epirubicin—sarcoma	0.00415	0.00415	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Doxorubicin—sarcoma	0.00397	0.00397	CcSEcCtD
Bisacodyl—Hypersensitivity—Epirubicin—sarcoma	0.00387	0.00387	CcSEcCtD
Bisacodyl—Abdominal pain—Doxorubicin—sarcoma	0.00384	0.00384	CcSEcCtD
Bisacodyl—Diarrhoea—Epirubicin—sarcoma	0.00359	0.00359	CcSEcCtD
Bisacodyl—Hypersensitivity—Doxorubicin—sarcoma	0.00358	0.00358	CcSEcCtD
Bisacodyl—Dizziness—Epirubicin—sarcoma	0.00347	0.00347	CcSEcCtD
Bisacodyl—Vomiting—Epirubicin—sarcoma	0.00334	0.00334	CcSEcCtD
Bisacodyl—Diarrhoea—Doxorubicin—sarcoma	0.00333	0.00333	CcSEcCtD
Bisacodyl—Headache—Epirubicin—sarcoma	0.00329	0.00329	CcSEcCtD
Bisacodyl—Dizziness—Doxorubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Bisacodyl—Nausea—Epirubicin—sarcoma	0.00312	0.00312	CcSEcCtD
Bisacodyl—Vomiting—Doxorubicin—sarcoma	0.00309	0.00309	CcSEcCtD
Bisacodyl—Headache—Doxorubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Bisacodyl—Nausea—Doxorubicin—sarcoma	0.00289	0.00289	CcSEcCtD
